$0.00
1
6
$0.00
1
6
Trader mode: Actionable analysis for identifying opportunities and edge
Lonvoguran Ziclumeran (lonvo-z) - BLA If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran, lonvo-z, to the FDA before X 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.
AI-generated analysis based on market data. Not financial advice.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
6 markets tracked
No data available
| Market | Platform | Price |
|---|---|---|
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027) | Kalshi | 69% |
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027) | Kalshi | 64% |
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December) | Kalshi | 60% |
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November) | Kalshi | 57% |
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October) | Kalshi | 48% |
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before September) | Kalshi | 41% |
No related news found
Add this market to your website
<iframe src="https://predictpedia.com/embed/CQdin6" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="When will Intellia Therapeutics submit a BLA for Lonvo-z?"></iframe>